Prescription drug · NDA
As-3 NDC 87069-462
Adenine .03 g/100mL; Dextrose, Unspecified form 1 g/100mL · Solution · Intravenous · GVS TM INC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 87069-462-33 | 87069046233 | 25 BAG in 1 CARTON (87069-462-33) / 300 mL in 1 BAGMarketed from Sep 15, 2025 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- As-3
- Generic name (nonproprietary)
- as-3
- Active ingredients
- Adenine — .03 g/100mLDextrose, Unspecified form — 1 g/100mL
- Dosage form
- Solution
- Route
- Intravenous
- Labeler
- GVS TM INCNDC labeler code 87069
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication BN 820915
- Marketing start
- Listing expires
- Identifiers
- Product ID 87069-462_42ecbc27-e538-a151-e063-6394a90ad89eSPL ID 42ecbc27-e538-a151-e063-6394a90ad89eSPL set ID 3dfa3397-fc13-4659-e063-6394a90a5abcUNII JAC85A2161, IY9XDZ35W2
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N487069046233followed by a unit qualifier and the quantityPackage 87069-0462-33. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
About NDC 87069-462
- What is NDC 87069-462?
- 87069-462 is the product NDC for As-3, Adenine .03 g/100mL; Dextrose, Unspecified form 1 g/100mL solution, listed with the FDA by GVS TM INC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- As-3.
- What is the active ingredient?
- Adenine, Dextrose, Unspecified form.
- Who is the labeler?
- GVS TM INC, NDC labeler code 87069. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for As-3?
- 1 other product NDC are listed under this name. See all As-3 NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other As-3 products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| As-3 | Adenine .03 g/100mL; Dextrose, Unspecified form 1 g/100mL | SolutionIntravenous | GVS TM INC | 87069-460 | 87069-0460-42 |
Other NDCs under BN 820915
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| As-3 | Adenine .03 g/100mL; Dextrose, Unspecified form 1 g/100mL | SolutionIntravenous | GVS TM INC | 87069-460 |
| Blood Collection Systemcp2d/as-3 triple with sampling system | Dextrose, Unspecified form 3.57 g/70mL | SolutionIntravenous | GVS TM INC | 87069-121 |
| Cp2D | Dextrose, Unspecified form 4.64 g/100mL | SolutionIntravenous | GVS TM INC | 87069-455 |
| Leukotrap RC PL Systemcp2d/as-3 anticoagulant and additive system | Dextrose, Unspecified form 3.57 g/70mL | SolutionIntravenous | GVS TM INC | 87069-123 |
| Leukotrap RC Systemcp2d/as-3 anticoagulant and additive system | Dextrose, Unspecified form 3.57 g/70mL | SolutionIntravenous | GVS TM INC | 87069-129 |
| Leukotrap WB System - CP2Dcp2d/as-3 - anticoagulant and additive system | Dextrose, Unspecified form 3.57 g/70mL | SolutionIntravenous | GVS TM INC | 87069-126 |
| Leukotrap WB system - CP2Dcp2d/as-3 anticoagulant and additive system | Dextrose, Unspecified form 3.21 g/63mL | SolutionIntravenous | GVS TM INC | 87069-726 |